Eugia Pharma Specialities Ltd., a fully integrated subsidiary of Aurobindo Pharma, specializes in general injectables and oncology, boasting a comprehensive portfolio that spans various therapeutic areas. The company operates globally with facilities and teams in the USA, Europe, Brazil, Mexico, Canada, Colombia, ANZ, and select RoW markets, employing over 150 scientists and 4,000 staff worldwide. Eugia aims to build an extensive speciality portfolio.
The portfolio includes a range of injectable products like Penems, Penicillin, Cephalosporin, along with Ophthalmic, Inhalation (Respules), Oncology, and Hormone products.
Dispensing systems encompass Vials (SDV and MDV), Ampoules, Bags, Pre-filled Syringes, Cartridges, Pen-products, Tablets, and Capsules.
The company boasts four fully commercialized state-of-art manufacturing facilities with one more upcoming facility.
Aspiring to be amongst the top five global leaders in the sterile generic sterile & market, renowned for quality and superior customer experience.
To become the most valued Indian generic specialty pharma company, and continually advancing a diverse range of specialty pharmaceuticals that meet the highest regulatory standards.
Continual investment in complex injectables and advanced R&D in Hyderabad underscores Eugia’s commitment to innovation, particularly in developing peptides, long-acting injectables, and sophisticated ophthalmic and dry powder injections.
© Copyright 2025 Aurobindo Pharma Limited. All rights reserved.